ArticleScience translational medicine2016

PIK3CA mutations enable targeting of a breast tumor dependency through mTOR-mediated MCL-1 translation.

Gray R Anderson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.